Page last updated: 2024-09-03

mk 0663 and safrole

mk 0663 has been researched along with safrole in 1 studies

Compound Research Comparison

Studies (mk 0663)	Trials (mk 0663)	Recent Studies (post-2010) (mk 0663)	Studies (safrole)	Trials (safrole)	Recent Studies (post-2010) (safrole)
549	173	265	618	2	177

Protein Interaction Comparison

Protein	Taxonomy	mk 0663 (IC50)	safrole (IC50)
Cytochrome P450 1A2	Homo sapiens (human)		10

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amat, M; Caturla, F; Córdoba, M; Reinoso, RF; Warrellow, G	1

Other Studies

1 other study(ies) available for mk 0663 and safrole

Article	Year
Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx and Arcoxia. Bioorganic & medicinal chemistry letters, 2006, Jun-15, Volume: 16, Issue:12 Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Humans; Isomerism; Lactones; Male; Molecular Structure; Prodrugs; Pyridines; Rats; Rats, Wistar; Safrole; Solubility; Sulfones; Temperature; Thermodynamics	2006

Article

Year

Racemic and chiral sulfoxides as potential prodrugs of the COX-2 inhibitors Vioxx and Arcoxia.

Bioorganic & medicinal chemistry letters, 2006, Jun-15, Volume: 16, Issue:12

Topics: Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Humans; Isomerism; Lactones; Male; Molecular Structure; Prodrugs; Pyridines; Rats; Rats, Wistar; Safrole; Solubility; Sulfones; Temperature; Thermodynamics

2006